Eli Lilly Opens R&D Center In Shanghai To Develop Targeted Drugs
Eli Lilly inaugurated a research center in Shanghai aimed at producing drugs to meet the new demand for personalized treatments, primarily for diabetes in Chinese patients.
Original Article: Eli Lilly Opens R&D Center In Shanghai To Develop Targeted Drugs
NEXT ARTICLE